Research Only Use:

CJC-1295 is sold strictly for in vitro laboratory research use only. It is not intended for human consumption, clinical use, or veterinary applications. No claims are made regarding safety or efficacy for therapeutic purposes.

CJC-1295

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog developed for scientific research involving endocrine physiology, growth hormone regulation, and metabolic signaling. Engineered to provide an extended duration of activity through structural modifications, CJC-1295 has become a widely studied investigational peptide in laboratory and preclinical research focused on the regulation of growth hormone secretion and insulin-like growth factor-1 (IGF-1) production. Its prolonged biological activity makes it a valuable research tool for examining hormonal signaling pathways and their influence on metabolism, tissue physiology, and cellular communication.

Researchers investigate CJC-1295 for its ability to bind selectively to growth hormone-releasing hormone receptors located within the anterior pituitary gland. Activation of these receptors stimulates the physiological release of endogenous growth hormone, which subsequently influences the production of insulin-like growth factor-1 (IGF-1). Experimental studies continue to examine how this hormone-regulating cascade affects protein synthesis, cellular metabolism, tissue remodeling, and overall endocrine function. Because CJC-1295 promotes the body’s natural growth hormone release rather than directly supplying growth hormone, it provides an important model for studying endogenous hormonal regulation.

Scientific investigations involving CJC-1295 extend across several disciplines, including endocrinology, metabolic physiology, muscle biology, and regenerative medicine. Laboratory studies evaluate its potential influence on body composition, skeletal muscle physiology, lipid metabolism, glucose regulation, and energy utilization. Additional research explores its interaction with molecular signaling pathways involved in tissue maintenance, bone metabolism, mitochondrial function, and cellular adaptation to metabolic stress. These ongoing investigations continue to improve scientific understanding of growth hormone physiology and endocrine regulation.

Researchers also utilize CJC-1295 in experimental models examining healthy aging, recovery physiology, and hormonal homeostasis. Studies continue to investigate how prolonged stimulation of growth hormone-releasing hormone receptors may influence cellular communication, metabolic efficiency, and the coordinated regulation of endocrine pathways. While research continues to expand, CJC-1295 remains an investigational peptide intended exclusively for laboratory and scientific study.

Manufactured using advanced solid-phase peptide synthesis technology, CJC-1295 is produced under stringent quality control standards to ensure exceptional purity, identity, and batch-to-batch consistency. Every production lot undergoes comprehensive analytical testing to verify peptide composition and quality, supporting reliable laboratory performance and reproducible scientific outcomes. These manufacturing standards make CJC-1295 suitable for controlled research environments where precision and consistency are essential.

Supplied as a lyophilized peptide, CJC-1295 offers excellent stability for laboratory applications when handled according to established research protocols. Proper reconstitution, storage, and handling procedures help preserve peptide integrity and maintain consistent experimental performance throughout scientific investigations.

CJC-1295 Features

• High-purity synthetic growth hormone-releasing hormone (GHRH) analog
• Extended-duration peptide for endocrine research
• Manufactured using advanced peptide synthesis technology
• Produced under stringent quality control standards
• Batch tested for purity, identity, and consistency
• Supplied as a lyophilized research peptide
• Designed exclusively for laboratory and scientific research

Research Applications

CJC-1295 is commonly investigated in studies involving:

• Growth hormone-releasing hormone (GHRH) signaling
• Growth hormone secretion
• IGF-1 regulation
• Endocrine physiology
• Metabolic regulation
• Protein synthesis pathways
• Muscle biology
• Bone metabolism
• Glucose metabolism
• Lipid metabolism
• Cellular signaling
• Healthy aging research

Storage

Store the lyophilized peptide refrigerated at 2°C–8°C for short-term storage or frozen for long-term preservation in accordance with accepted laboratory best practices. Protect the product from moisture, repeated freeze-thaw cycles, excessive heat, and direct light to maintain peptide stability and product integrity.

Important Notice

CJC-1295 is supplied strictly for laboratory research purposes only. It is not intended for human consumption, veterinary use, therapeutic applications, or diagnostic purposes. This product has not been evaluated or approved by regulatory authorities for the diagnosis, treatment, cure, or prevention of any disease. It should be handled only by qualified professionals in appropriate research facilities while following all applicable laboratory safety procedures and regulatory requirements.